Coronavirus Resources
The emergence of COVID-19, the novel coronavirus disease, as a global pandemic is a clear reminder of the importance of investment in research to better understand how to prevent and treat disease. It also underscores why we need to greatly strengthen our public health capacity against such threats. We know COVID-19 is top of mind for you, and it is for us, too. Research!America is working hard to assure federal funding and policy actions are evidence-based and match the urgency needed. We will continue to keep you up-to-date about important advocacy opportunities so you can join with us. Let’s call on policymakers to match the abundance of caution we are all so importantly practicing now with an abundance of research.
This page features resources from Research!America and our many expert partners. Please use and share these trusted resources in your own work, for advocacy, on social media, and with neighbors, family, and friends.
New
NIH has a new COVID-19 website. The website features news on the latest NIH research, funding opportunities, and information on how to join a clinical trial.
U.S. Government Resources
-
Title-by-title summary of the $8.3 billion Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (PDF)
-
The House Oversight Committee hearings on coronavirus preparedness and response:
-
ARHQ's COVID-19 Resources
-
CDC Coronavirus Disease 2019 (COVID-19) Situation Summary
-
CDC COVID-19 Social Media Toolkit
-
Department of Health and Human Services (HHS) Office of the Inspector General COVID-19 Portal
-
NIH Coronavirus Disease (COVID-19) Situation Summary and Resources
-
NSF Coronavirus Information Guidance and Rapid Research
-
FDA Resources, including What’s New, FAQ’s, FDA’s Role, Medical Countermeasures, Health Fraud, and more
- BARDA 2019 nCoV Market Research: BARDA is providing a portal for the U.S. government 2019 novel coronavirus (2019-nCoV) medical countermeasures task force to provide a single point of entry for the submission of market research packages from interested stakeholders.
The Department of Health & Human Services (HHS), in coordination with NIH and Operation Warp Speed, has launched a central web portal called Combat COVID (https://combatcovid.hhs.gov/).
The portal is a one-stop resource to help members of the public and doctors find information about different stages of COVID-19 illness, NIH-supported COVID-19 prevention and treatment clinical trials, and locations to donate plasma. The website provides clear and easy-to-understand information for:
- People who have never had COVID-19 who may be interested in joining a vaccine or other prevention trial
- People who have COVID-19 and want to participate in a treatment clinical trial
- People who have recovered from COVID-19 who may be interested in donating plasma
- Doctors and other healthcare providers who want more information to guide their patients who have COVID-19
Visit combatCOVID.hhs.gov to learn more.
Research!America Resources
Public Opinion Survey Data
- Americans Agree: Improving Our Public Health System is an Urgent Priority (October 2020)
- National survey shows bipartisan committment to science (October 2020)
- 2020 National Survey with vaccine questions
- 2018 Global Health and Infectious Diseases
Fact Sheets/Infographics
Research!America Alliance member events
-
Alliance member webinar on January 11, 2020 with Dr. Larry Tabak, Principal Deputy Director of the National Institutes of Health, and Dr. Michael Lauer, NIH Deputy Director of Extramural Research, who discussed updates for FY21 NIH grants and answered audience questions.
-
Alliance member webinar on December 3, 2020, with Dr. Alan Peterson, who joined us to discuss the critical intersection between the pandemic and mental health, including depression and PTSD.
-
Alliance member webinar on October 15, 2020, on ClinicalTrials.gov with Anna Fine and Becky Williams exploring the role ClinicalTrials.gov is playing in COVID-19 information-sharing and the status of a major ClinicalTrials.gov modernization project.
-
Alliance member webinar on September 30, 2020, with Dr. Larry Tabak, Principal Deputy Director of the National Institutes of Health, who discussed how NIH is addressing the current funding situation due to COVID-19 and the outlook for FY2021 grants/
-
Alliance member webinar on July 27, 2020, with Eliseo J. Pérez-Stable, MD, Director of the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health (NIH), who discussed the Institute's COVID-19 response and racial and ethnic disparities in the pandemic’s impact.
-
Alliance member webinar on July 23, 2020, with Judy Salerno, MD, MS, president, New York Academy of Medicine, who shared her experience returning to clinical work at Bellevue Hospital during the height of the COVID-19 crisis in New York City.
-
Alliance member webinar on July 13, 2020, with Gary Gibbons, MD, Director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH). Dr. Gibbons discussed NHLBI's COVID-19 response given the significance of heart and lung conditions, racial and ethnic disparities in the pandemic’s impact, and the effect of COVID-19 on research outside the pandemic’s sphere.
-
Alliance member webinar July 9, 2020, with Chris Austin, MD, Director of the National Center for Advancing Translational Sciences at the National Institutes of Health. Dr. Austin discussed about NCATS's new Open Data Portal, National COVID Cohort Collaborative and other NCATS priorities.
-
Alliance member webinar on June 29, 2020, with former CDC Director Tom Frieden, MD, President and CEO of Resolve to Save Lives, an initiative of Vital Strategies, to discuss how to expedite the resources needed when pandemics and other national public health emergencies arise.
-
Alliance member webinar on June 24, 2020, with Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) at NIH and Patrick J. Kennedy, Former U.S. Representative (D – RI) and Founder of the Kennedy Forum.
-
Alliance member webinar on June 19, 2020, featuring Dr. Jeff Allen, President and CEO of Friends of Cancer Research (Friends). Dr. Allen spoke about the halted clinical trials and the long term impacts of COVID-19 on clinical research.
-
Alliance member webinar on June 1, 2020, featuring Dr. Josh Gordon, Director of the National Institute of Mental Health (NIMH). Dr. Gordon discussed the Institute’s work about NIMH's COVID-19 response and the critical intersection between the pandemic and mental health.
-
Alliance member webinar on May 22, 2020, featuring Dr. Victor Dzau of the National Academies of Medicine. Dr. Dzau discussed the NAM's work related to COVID-19.
-
Alliance member webinar on May 11, 2020, featuring The Honorable Louis W. Sullivan, former Secretary of Health and Human Services and Chairman, Sullivan Alliance to Transform the Health Professions. He spoke about health disparities in the context of COVID-19 and the importance of effective communication about public health.
-
Alliance Member Call on May 6, 2020, featuring Dr. Peter Hotez, Dean of the Baylor School of Medicine National School of Tropical Medicine. Dr. Peter Hotez spoke about the history of vaccines, COVID-19 vaccine development, and the spread of the novel coronavirus across the southern hemisphere. He also spoke about the anti-science and anti-vaccine movements in our country and globally. You can watch the meeting here and you can view his slides here.
-
Alliance member call on April 30, 2020, featuring Dr. Francis Collins, Director of NIH, and Dr. Keith Yamamoto, Professor Emeritus, Vice Chancellor for Science Policy and Strategy, and Director, UCSF Precision Medicine at UC San Francisco. Dr. Collins provided an overview of NIH’s unprecedented Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) and the Rapid Acceleration of Diagnostics (RADx) Initiative. Dr. Yamamoto discussed the impact of COVID-19 on the research ecosystem and highlighted some of the collaborations taking place to respond to the pandemic.
-
Alliance member call on April 28, 2020: Donna Cryer, President and CEO of the Global Liver Institute (GLI) and interim director of the National Patient-Centered Research Network (PCORnet). Donna shared updates on GLI's comprehensive COVID-19 response program, including a popular Facebook Live series for the patient, caregiver, and research community (in other words, for all of us!) Leslie Ritter, the Senior Director of Advocacy at the National Multiple Sclerosis Society (NMSS) also joined us to discuss the disruptive impact of COVID-19 on research supported by voluntary health associations, philanthropies, and scientific societies. Contact Leslie to join an advocacy effort focused on addressing this challenge. See the recording here (registration required.)
-
Alliance member call on April 20, 2020: Dr. Harvey Fineberg, President of the Gordon and Betty Moore Foundation and chair of the National Academies Standing Committee on Emerging Infectious Diseases joined us for an alliance member call to discuss COVID-19.
-
Alliance member call on April 15, 2020: Scott Whitaker, President and CEO of AdvaMed discussed how the medical device and diagnostic sectors are working on to combat the pandemic. Dr. Rick Bright, Deputy Assistant Secretary for Preparedness and Response and the Director of the Biomedical Advanced Research and Development Authority (BARDA) provided an update on BARDA's COVID-19 efforts.
-
Alliance member call on April 7, 2020 with Dr. Georges Benjamin, executive director of the American Public Health Association, where he discussed the nationwide response to COVID-19 and National Public Health Week. Viewers will need to provide basic registration information to access.
-
Alliance member call on March 24, 2020 (viewers will need to provide basic registration information to access) with Dr. David Skorton, president of the Association of American Medical Colleges (AAMC). Dr. Skorton and members of his team discussed strategies academic health centers are employing to address COVID-19 and answered questions from the audience. Follow-up blog post from Dr. Skorton: "To address COVID-19 and future pandemics, we must address fundamental questions."
-
Teleconference on March 16, 2020 (viewers will need to provide basic registration information to access) with Dr. Larry Tabak, Principal Deputy Director of the National Institutes of Health, and Dr. Michael Lauer, Deputy Director for Extramural Research. The topic was NIH’s efforts to ensure research institutions and scientists are accorded the flexibility needed as they confront COVID-19-related research disruptions.
-
2019 National Health Research Forum: Centers for Disease Control Mission and Public Health Priorities | Dr. Robert Redfield, director of the Centers for Disease Control and Prevention, was one of many keynote speakers at a day-long forum hosted by Research!America. Dr. Redfield focused on his agency’s mission and public health priorities.:
-
2018 Briefing by Research!America and the American Society for Microbiology (ASM): Vaccines and stronger public health infrastructures are critical to tackle global health threats, said experts at a briefing hosted by Research!America and the American Society for Microbiology (ASM) at the Newseum in Washington, D.C. on May 21, 2018:
- Health experts talked about the spread of infectious diseases and what the U.S. is doing to prevent potential outbreaks on May 21, 2018. Speakers included the head of the National Center for Immunization and Respiratory Diseases and the director of the National Institutes of Health. Includes Dr. Anthony Fauci (NIAID), Dr. Nancy Messonier (CDC) Dr. Stacey Schultz-Cherry (American Society for Virology)
webinars
- Webinar: Understanding the Landscape of COVID-19 Vaccine and Treatment R&D featuring Mark McClellan, Stefano Bertuzzi, and Julie Gerberding. This webinar provided a high-level overview of the most promising scientific approaches underway to create vaccines, treat COVID-19 symptoms, cure serious cases, and prevent infection. Panelists discussed how the existing R&D pipeline is being leveraged to address COVID-19 and provided examples of public-private partnerships.
-
Partnership, Progress, Pandemic: The Impact of COVID-19 on Medical Discovery featuring Sudip Parikh, Ned Sharpless, Jenny Luray, Eleanor Perfetto, and Heather Pierce. View the recorded webinar here. This virtual roundtable discussion explored the impact of the COVID-19 pandemic on public and private sector-fueled medical progress. The panelists discussed the pandemic’s influence on the research NIH conducts and supports, our nation’s R&D infrastructure, the private sector investment climate, technology transfer and other key variables influencing the pace of medical progress, and opportunities to quickly reboot R&D as we move forward.
Other Resources
-
Research!America blogs related to COVID-19, including on diagnostics and serology.
-
Research!America Statement on Bipartisan COVID-19 Response, March 26, 2020
-
General Global Health Resources: Global Health R&D
-
Chemical and Engineering News: $8.3 Billion Allocated for U.S. Coronavirus Response Featuring Ellie Dehoney, Vice President of Policy and Advocacy
- Bloomberg Government: Agencies Fighting Coronavirus to See Cuts Under Budget Request Featuring Jenny Luray, Vice President of Strategy and Communications
Partner Resources
Universities and Research Institutions
-
Coronavirus Information Portal • UNC Gillings School of Global Public Health
-
Emory University Rollins School of Public Health FAQs and Resources: COVID-19
-
Johns Hopkins live-updated map of COVID-19 cases Johns Hopkins Coronavirus Resource Center
-
Johns Hopkins Bloomberg School of Public Health (digital library): COVID-19: School of Public Health Digital Library
-
Harvard School of Public Health: The latest on the coronavirus | News | Harvard TH Chan School of Public Health
-
Memorial Sloan Kettering Cancer Center: The 2019 Novel Coronavirus (COVID-19): Key Facts and What It Means for People with Cancer
-
Milken Institute School of Public Health at the George Washington University campus advisories and information: COVID-19
-
Milken Institute COVID-19 Vaccine tracker
-
University of California, San Francisco COVID-19 Response and Experts
-
University of Maryland School of Public Health community guidance and information: Coronavirus Information
-
Stanford University School of Medicine Coronavirus Information and Stanford University Evidence Service Report about PPE and Mask Safety
Nonprofits, Science Societies and Associations
-
AdvaMed: Learn more about how medical device industry is responding to COVID.
-
American Association for the Advancement of Science (Science): Coronavirus
-
American Public Health Association: COVID-19
-
Association of Public Land-Grant Universities: Includes guidance, university research, and examples of university communications. University Responses to the Coronavirus
-
American Thoracic Society Novel Coronavirus (COVID-19): The ATS Response (at bottom of page, see "other" for a listing of journal article collections relating to COVID-19 research)
-
American Society for Clinical Oncology: Coronavirus 2019: What People With Cancer Need to Know
-
American Society for Microbiology: Includes background information, updates, toolkits, resources, and more; COVID-19 Research Registry
-
CDC Foundation: Responding to Coronavirus
-
Federation of American Scientists: Coronavirus Project – Federation Of American Scientists
-
FAS website on COVID-19 including their "ask a scientist" function. The website is now available in English and Spanish and will soon be Alexa/Amazon enabled.
-
Federation of American Scientists: Resources with a focus on debunking misinformation
-
Global Health Technologies Coalition COVID-19 R&D Tracker
-
Infectious Disease Society of America: IDSA Home
Industry Resources
- Amgen: COVID-19 Information Center
- BD: COVID-19 Point of Care Antigen Testing (video)
- Elsevier: Novel Coronavirus Information Center
- GSK: GSK actions to support the global response to COVID-19
- Lilly's Global COVID-19 Response
- Pfizer Outlines 5-Point Plan to Battle COVID-19
- JLABS Invisible Shield QuickFire Challenge